Edwards Lifesciences looks forward to seeing you at AATS 2024
Join our symposium
Edwards Lifesciences is sponsoring a lunch symposium at AATS 2024. Click on the calendar invitation below to add this event to your calendar and we'll see you there!
Tick tock, the AR clock: Choosing valve replacement in chronic aortic regurgitation
Saturday, April 27th
12:00 PM - 1:00 PM ET
Metro Toronto Convention Center
Join us at booth #1005 to experience the RESILIA tissue portfolio difference
Edwards Lifesciences is advancing the future of cardiac surgery with a growing portfolio of valves designed with RESILIA tissue. Today's RESILIA tissue portfolio represents the best of creative scientific minds coming together to address unmet needs and satisfy patient demands for better surgical options.
Visit the booth to explore our portfolio of RESILIA tissue valves.
MITRIS
RESILIA Mitral Valve
INSPIRIS
RESILIA Aortic Valve
KONECT
RESILIA Aortic Valved Conduit
This industry symposia will be held in conjunction with the AATS Annual Meeting. It is not part of the official AATS scientific program. Continuing Medical Education (CME) credit for this activity is not offered by AATS.
Important Safety Information: RESILIA Tissue Devices
Indications: INSPIRIS RESILIA Aortic Valve - For use in replacement of native or prosthetic aortic heart valves. KONECT RESILIA Aortic Valved Conduit - For use in replacement of native or prosthetic aortic heart valves and the associated repair or replacement of a damaged or diseased ascending aorta. MITRIS RESILIA Mitral Valve - For use in replacement of native or prosthetic mitral heart valves.
Contraindications: There are no known contraindications with the use of these RESILIA tissue heart valve devices.
Complications and Side Effects: INSPIRIS RESILIA Aortic Valve - Thromboembolism, valve thrombosis, hemorrhage, hemolysis, regurgitation, endocarditis, structural valve deterioration, nonstructural dysfunction, stenosis, arrhythmia, transient ischemic attack/stroke, congestive heart failure, myocardial infarction, any of which could lead to reoperation, explantation, permanent disability, and death. Additional adverse events potentially associated with the use of polyester vascular grafts in the KONECT RESILIA AVC include hemorrhage, thrombosis, graft infection, embolism, aneurysm, pseudoaneurysm, seroma, occlusion (anastomotic intimal hyperplasia), immunological reaction to collagen (shown to be a weak immunogen; infrequent, mild, localized and self-limiting), intimal peel formation, and conduit dilatation. MITRIS RESILIA Mitral Valve - Thromboembolism, valve thrombosis, hemorrhage, hemolysis, regurgitation, endocarditis, structural valve deterioration, nonstructural dysfunction, stenosis, arrhythmia, transient ischemic attack/stroke, congestive heart failure, myocardial infarction, ventricular perforation by stent posts, any of which could lead to reoperation, explantation, permanent disability, and death.
Warnings: INSPIRIS RESILIA Aortic Valve - DO NOT ADJUST THE VALVE DIAMETER BY EXPANDING THE BAND PRIOR TO OR DURING IMPLANTATION OF THE SURGICAL VALVE. The expandable band is not designed to allow for compression or expansion during implantation of the surgical valve. This will cause damage to the valve and may result in aortic incompetence. DO NOT PERFORM STAND-ALONE BALLOON AORTIC VALVULOPLASTY PROCEDURES ON THIS VALVE FOR THE SIZES 19 – 25 mm as this may expand the valve causing aortic incompetence, coronary embolism or annular rupture. Valve-in-valve sizing in the INSPIRIS valve has only been tested with specific Edwards transcatheter heart valves. Use of other transcatheter valves may result in embolization of transcatheter devices anchored within or result in annular rupture.
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician. See Instructions for Use for full prescribing information.
Edwards, Edwards Lifesciences, the stylized E logo, INSPIRIS, INSPIRIS RESILIA, KONECT, KONECT RESILIA, MITRIS, MITRIS RESILIA, and RESILIA are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.
© 2024 Edwards Lifesciences Corporation. All rights reserved. PP--US-9489 v1.0
Edwards Lifesciences • One Edwards Way, Irvine CA 92614 USA • edwards.com